Living in rural households decreases a person’s risk of developing inflammatory bowel disease (IBD), particularly for young children and adolescents, according to a new study by researchers at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute, Institute for Clinical Evaluative Sciences (ICES), and the Canadian Gastro-Intestinal Epidemiology Consortium (CanGIEC). “Our findings show that children, particularly those under the age ...
Read More »Tag Archives: GI
Fujifilm Announces the Launch of Two New Products for GI Endoscopic Submucosal Dissection (ESD) Procedures
FUJIFILM Medical Systems U.S.A., Inc. today announced the launch of two new additions to its advanced endoscopic platform including ClutchCutter and FlushKnife devices. Designed for use with compatible endoscopes, these devices aid clinicians in performing effective endoscopic submucosal dissection (ESD) interventions within the digestive tract. “Gastrointestinal diseases—including cancers—affect some 60 to 70 million Americans annually,” said Keiichi Nagata, Division President, FUJIFILM Medical ...
Read More »VolitionRx presents at World Congress of GI Endoscopy
VolitionRx Limited (NYSE MKT: VNRX) has presented data at the World Congress of GI Endoscopy (ENDO) 2017 conference in Hyderabad, India, from a study that confirms prior test results that the Nu.QTM Colorectal Cancer Screening Triage test reduces the total number of colonoscopy referrals while maintaining high sensitivity for cancer detection. “This is a key clinical milestone in the launch of our Nu.QTM Triage product. This ...
Read More »Tillotts Pharma in Germany Dedicated to Gastrointestinal Health
Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort® for the treatment of Crohn’s disease, Asacol® for the treatment of ulcerative colitis, and VistaPrep® for bowel preparation before endoscopy. With further innovative solutions, the Swiss specialty pharmaceutical company focused on the treatment of gastrointestinal (GI) diseases will expand its global footprint with its growing presence in Germany and will continue to work to improve the quality ...
Read More »Improving key diagnostic measures for gastrointestinal disorders
With no laboratory test available to diagnose functional gastrointestinal disorders, proper diagnostic criteria are critical for clinicians to make an accurate determination of what ails their patients. Several University of North Carolina School of Medicine researchers played a key role in crafting diagnostic criteria and patient questionnaires for the Rome Foundation, an international nonprofit aimed at improving the lives of ...
Read More »